Climb Bio to participate in upcoming investor conferences
Climb Bio said members of its executive team will participate in upcoming investor conferences, per the company’s announcement.
WELLESLEY HILLS, Mass., Sept.
02, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc.
NASDAQ:CLYM, a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that members of its executive team will participate in the upcoming conferences detailed…